After years towards higher field strength magnets, nuclear magnetic resonance (NMR) technology in commercial instruments in the past decade has expanded at low and high magnetic fields to take advantage of new opportunities. At lower field strengths, permanent magnets are well established, whereas for midrange and high field, developments utilize superconducting magnets cooled with cryogenic liquids. Recently, the desire to locate NMR spectrometers in nontypical NMR laboratories has created interest in the development of cryogen‐free magnets. These magnets require no cryogenic maintenance, eliminating routine filling and large cryogen dewars in the facility. Risks of spontaneous quenches and safety concerns when working with cryogenic liquids are eliminated. The highest field commercially available cryogen‐free NMR magnet previously reported was at 4.7 T in 2013. Here we tested a prototype cryogen‐free 9.4‐T power‐driven high‐temperature‐superconducting (HTS) magnet mated to commercial NMR spectrometer electronics. We chose cinacalcet HCl, a typical active pharmaceutical ingredient, to evaluate its performance towards structure elucidation. Satisfactory standard 1D and 2D homonuclear and heteronuclear NMR results were obtained and compared with those from a standard 9.4‐T cryogenically cooled superconducting NMR instrument. The results were similar between both systems with minor differences. Further comparison with different shims and probes in the HTS magnet system confirmed that the magnet homogeneity profile could be matched with commercially available NMR equipment for optimal results. We conclude that HTS magnet technology works well providing results comparable with those of standard instruments, leading us to investigate additional applications for this magnet technology outside a traditional NMR facility.
Although when reading an article the abstract is the first element it may be prudent to make this the last element in the composition of the manuscript. This will enable one to keep consistent with the findings of the research and prevent rewriting as the investigative components of the article develop.
III. Referencing
When it comes to referencing, MRC adopts the Vancouver style however the
journal’s production team will reformat most styles of references into
the specific MRC Vancouver variant provided that all of the necessary components to create
the style are present.
In text citations: MRC's reference style uses superscript numbers within the article which are embedded in square brackets for example; [1]. These are numbered consecutively by order or appearance. Authors should use a comma rather than an en dash between two consequtive reference citations, for example; [1,2]. An en dash should be used when indicating a range of citations, for example; [5-8].
Reference list: In text citations are supplemented with a reference list at the end of the article. Each entry in this list appear in the order of appearance without square brackets, for example; 1.
As an author, it is advantageous to use
referencing software to enable reformatting in the event that the
article is not publishable by MRC and an alternate publication is
chosen.
IV. Presentation of spectra
V. Spectral assignment, requirements
VI. Accepted terms/nomenclature/abbreviations and terminology
VII. Supplementary material
VIII. Provision of raw data
IX. NMReDATA